Genetic risk factors and candidate biomarkers for Alzheimer's disease

Frontiers in Bioscience - Scholar

Volumn 2 S, Issue 2, 2010, Pages 616-622

  Scapagnini, Giovanni ^a   Caruso, Calogero ^b   Vasto, Sonya ^b   Pascale, Alessia ^c   Romeo, Loriana ^d   D'Agata, Velia ^e   Intrieri, Mariano ^a   Sapere, Nadia ^a   Li Volti, Giovanni ^e,f  

^a UNIVERSITY OF MOLISE   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

^c UNIVERSITY OF PAVIA   (Italy)

^d INSTITUTE OF NEUROLOGICAL SCIENCES   (Italy)

^e UNIVERSITY OF CATANIA   (Italy)

^f OASI RESEARCH INSTITUTE IRCCS   (Italy)

Author keywords

Alzheimer's disease; Beta amyloid; Biomarkers; Heme oxygenase 1; Neurodegeneration; Oxidative stress; P53; Review

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E; BIOLOGICAL MARKER; TAU PROTEIN;

ALZHEIMER DISEASE; GENETICS; HUMAN; METABOLISM; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; APOLIPOPROTEINS E; BIOLOGICAL MARKERS; HUMANS; RISK FACTORS; TAU PROTEINS;

EID: 77954996257     PISSN: 19450516     EISSN: 19450524     Source Type: Journal    
DOI: 10.2741/s89     Document Type: Review

References (60)

1. MS Forman, JQ Trojanowski, VM Lee: Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med 10, 1055-1063 (2004) (Pubitemid 39424865)
2. DM Skovronsky, VM Lee, JQ Trojanowski: Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol 1, 151-170 (2006)
3. LJ Thal, K Kantarci, EM Reiman, WE Klunk, MW Weiner, H Zetterberg, D Galasko, D Praticò, S Griffin, D Schenk, E Siemers: The role of biomarkers in clinical trials for Alzheimer's disease. Alzheimer Dis Assoc Disord 20, 6-15 (2006) (Pubitemid 44356888)
4. CM Clark, C Davatzikos, A Borthakur, A Newberg, S Leight, VM Lee, JQ Trojanowski: Biomarkers for early detection of Alzheimer pathology. Neurosignals 16, 11-18 (2008) (Pubitemid 350308316)
5. R Cacabelos: Genomic characterization of Alzheimer's disease and genotype-related phenotypic analysis of biological markers in dementia. Pharmacogenomics 5, 1049-1105 (2004) (Pubitemid 40045250)
6. R Cacabelos: Pharmacogenomics and therapeutic prospects in dementia. Eur Arch Psychiatry Clin Neurosci 258, 28-47 (2008) (Pubitemid 351424036)
7. R Cacabelos, A Alvarez, V Lombardi, L Fernández-Novoa, L Corzo, P Pérez, M Laredo, V Pichel, A Hernández, M Varela, J Figueroa, J Jr Prous, M Windisch, C Vigo: Pharmacological treatment of Alzheimer disease: from psychotropic drugs and cholinesterase inhibitors to pharmacogenomics. Drugs Today (Barc) 36, 415-499 (2000)
8. P Kienlen-Campard, S Miolet, B Tasiaux, JN Octave: Intracellular amyloid-beta 1-42 but not extracellular soluble amyloid-beta peptides induces neuronal apoptosis. J Biol Chem 277, 15666-15670 (2002) (Pubitemid 34967839)
9. K Blennow, MJ de Leon, H Zetterberg: Alzheimer's disease. Lancet 368, 387-403 (2006) (Pubitemid 44108123)
10. K Iqbal, AC Alonso, S Chen, MO Chohan, E El-Akkad, CX Gong, S Khatoon, B Li, F Liu, A Rahman, H Tanimukai I Grundke-Iqbal: Tau pathology in Alzheimer disease and other tauopathies. Biochim. Biophys Acta 1739, 198-210 (2005) (Pubitemid 40018538)
11. TC Gamblin, F Chen, A Zambrano, A Abraha, S Lagalwar, AL Guillozet, M Lu, Y Fu, F Garcia-Sierra, N LaPointe, R Miller, RW Berry, LI Binder, VL Cryns: Caspase cleavage of tau: linking amyloid and neurofibrillary tangles in Alzheimer's disease. Proc Natl Acad Sci U S A 100, 10032-10037 (2003) (Pubitemid 37087063)
12. C Mancuso, G Scapagnini, D Currò, AM Giuffrida Stella, C De Marco, DA Butterfield, V Calabrese: Mitochondrial dysfunction, free radical generation and cellular stress response in neurodegenerative disorders. Front Biosci 12, 1107-1123 (2007) (Pubitemid 46846882)
13. V Crentsil: The pharmacogenomics of Alzheimer's disease. Ageing Res Rev 3, 153-169 (2004) (Pubitemid 38232679)
14. R Cacabelos: Pharmacogenomics for the treatment of dementia. Ann Med 34, 357-379 (2002) (Pubitemid 35351825)
15. AM, Saunders, WJ Strittmatter, D Schmechel, PH George-Hyslop, MA Pericak-Vance, SH Joo, BL Rosi, JF Gusella, DR Crapper-MacLachlan, MJ Alberts: Association of apolipoprotein E allele ε4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43, 1467-1472 (1993) (Pubitemid 23230526)
16. L Bertram, C Lange, K Mullin, M Parkinson, M Hsiao, MF Hogan, BM Schjeide, B Hooli, J Divito, I Ionita, H Jiang, N Laird, T Moscarillo, KL Ohlsen, K Elliott, X Wang, D Hu-Lince, M Ryder, A Murphy, SL Wagner, D Blacker, KD Becker, RE Tanzi: Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. Am J Hum Genet 83, 623-632 (2008)
17. F Panza, AM Colacicco, A D'Introno, C Capurso, M Liaci, SA Capurso, A Capurso, V Solfrizzi: Candidate genes for late-onset Alzheimer's disease: focus on chromosome 12. Mech Ageing Dev 127, 36-47 (2006) (Pubitemid 41713512)
18. BM Schjeide, B Hooli, M Parkinson, MF Hogan, J DiVito, K Mullin, D Blacker, RE Tanzi, L Bertram: GAB2 as an Alzheimer disease susceptibility gene: follow-up of genomewide association results. Arch Neurol 66, 250-254 (2009)
19. G Sármay, A Angyal, A Kertész, M Maus, D Medgyesi: The multiple function of Grb2 associated binder (Gab) adaptor/scaffolding protein in immune cell signaling. Immunol Lett 104, 76-82 (2006) (Pubitemid 43330712)
20. Y Liu, LR Rohrschneider: The gift of Gab. FEBS Lett 515, 1-7 (2002) (Pubitemid 34273887)
21. CH Reynolds, CJ Garwood, S Wray, C Price, S Kellie, T Perera, M Zvelebil, A Yang, PW Sheppard, IM Varndell, DP Hanger, BH Anderton: Phosphorylation regulates tau interactions with Src homology 3 domains of phosphatidylinositol 3-kinase, phospholipase Cγ1, Grb2, and Src family kinases. J Biol Chem 283, 18177-18186 (2008)
22. M Nizzari, V Venezia, E Repetto, V Caorsi, R Magrassi, MC Gagliani, P Carlo, T Florio, G Schettini, C Tacchetti, T Russo, A Diaspro, C Russo: Amyloid precursor protein and presenilin1 interact with the adaptor GRB2 and modulate ERK 1, 2 signaling. J Biol Chem 282, 13833-13844 (2007) (Pubitemid 47100564)
23. S Vasto, G Candore, G Duro, D Lio, MP Grimaldi, C Caruso: Alzheimer's disease and genetics of inflammation: a pharmacogenomic vision. Pharmacogenomics 8, 1735-1745 (2007)
24. F Listì, G Candore, CR Balistreri, MP Grimaldi, V Orlando, S Vasto, G Colonna-Romano, D Lio, F Licastro, C Franceschi, C Caruso: Association between the HLA-A2 allele and Alzheimer disease. Rejuvenation Res 9, 99-101 (2006)
25. D Di Bona, A Plaia, S Vasto, L Cavallone, F Lescai, C Franceschi, F Licastro, G Colonna-Romano, D Lio, G Candore, C Caruso: Association between the interleukin-1beta polymorphisms and Alzheimer's disease: a systematic review and meta-analysis. Brain Res Rev 59, 155-163 (2008)
26. K Blennow, E Vanmechelen, H Hampel: CSF total tau, Abeta42 and phosphorylated tau protein as biomarkers for Alzheimer's disease. Mol Neurobiol 24, 87-97 (2001) (Pubitemid 34066679)
27. K Blennow, H Hampel: CSF markers for incipient Alzheimer's disease. Lancet Neurol 2, 605-613 (2003) (Pubitemid 37162569)
28. CM Clark, S Xie, J Chittams, D Ewbank, E Peskind, D Galasko, JC Morris, DW Jr McKeel, M Farlow, SL Weitlauf, J Quinn, J Kaye, D Knopman, H Arai, RS Doody, C DeCarli, S Leight, VM Lee, JQ Trojanowski: Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses? Arch Neurol 60, 1696-1702 (2003) (Pubitemid 37521622)
29. H Arai, T Nakagawa, Y Kosaka, M Higuchi, T Matsui, N Okamura, M Tashiro, H Sasaki: Elevated cerebrospinal fluid tau protein level as a predictor of dementia in memory-impaired patients. Alzheimer's Research 3, 211-213 (1997) (Pubitemid 27475104)
30. P Schönknecht, J Pantel, T Hartmann, E Werle, M Volkmann, M Essig, M Amann, N Zanabili, H Bardenheuer, A Hunt, J Schröder: Cerebrospinal fluid tau levels in Alzheimer's disease are elevated when compared with vascular dementia but do not correlate with measures of cerebral atrophy. Psychiatry Res 120, 231-238 (2003) (Pubitemid 38366050)
31. H Hampel, K Buerger, R Kohnken, SJ Teipel, R Zinkowski, HJ Moeller, SI Rapoport, P Davies: Tracking of Alzheimer's disease progression with cerebrospinal fluid tau protein phosphorylated at threonine 231. Ann Neurol 49, 545-546 (2001) (Pubitemid 32281345)
32. D Galasko, C Clark, L Chang, B Miller, RC Green, R Motter, P Seubert: Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48, 632-635 (1997) (Pubitemid 27120097)
33. N Andreasen, L Minthon, P Davidsson, E Vanmechelen, H Vanderstichele, B Winblad, K Blennow: Evaluation of CSFtau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice. Arch Neurol 58, 373-379 (2005)
34. HA Crystal, P Davies: Toward a plasma marker for Alzheimer disease: Some progress, but still a long way to go. Neurology 70, 586-587 (2008) (Pubitemid 351294634)
35. HJ Frey, KM Mattila, MA Korolainen, T Pirttila: Problems associated with biological markers of Alzheimer's disease. Neurochem Res 30, 1501-1510 (2005) (Pubitemid 41818932)
36. JM Ringman, SG Younkin, D Pratico, JM Ringman, SG Younkin, D Pratico: Biochemical markers in persons with preclinical familial Alzheimer disease. Neurology 71, 85-92 (2008)
37. M Shi, WM Caudle, J Zhang: Biomarker discovery in neurodegenerative diseases: a proteomic approach. Neurobiol Dis 35, 157-164 (2009)
38. J Zhang, I Sokal, ER Peskind, JF Quinn, J Jankovic, C Kenney, KA Chung, SP Millard, JG Nutt, TJ Montine: CSF multianalyte profile distinguishes Alzheimer and Parkinson diseases. Am J Clin Pathol 129, 526-529 (2008) (Pubitemid 352029270)
39. AH Simonsen, J McGuire, VN Podust, H Davies, L Minthon, I Skoog, N Andreasen, A Wallin, G Waldemar, K Blennow: Identification of a novel panel of cerebrospinal fluid biomarkers for Alzheimer's disease. Neurobiol Aging 29, 961-968 (2008) (Pubitemid 351697984)
40. A Hye, S Lynham, M Thambisetty, M Causevic, J Campbell, HL Byers, C Hooper, F Rijsdijk, SJ Tabrizi, S Banner, CE Shaw, C Foy, M Poppe, N Archer, G Hamilton, J Powell, RG Brown, P Sham, M Ward, S Lovestone: Proteome-based plasma biomarkers for Alzheimer's disease. Brain 129, 3042-3050 (2006) (Pubitemid 44684524)
41. DC German: Serum biomarkers for Alzheimer's disease: proteomic discovery. Biomed Pharmacother 61, 383-389 (2007) (Pubitemid 47239345)
42. CR Balistreri, MP Grimaldi, S Vasto, F Listi, M Chiappelli, F Licastro, D Lio, C Caruso, G Candore: Association between the polymorphism of CCR5 and Alzheimer's disease: results of a study performed on male and female patients from Northern Italy. Ann N Y Acad Sci 1089, 454-461 (2006) (Pubitemid 47092067)
43. M Racchi, D Uberti, S Govoni, M Memo, C Lanni, S Vasto, G Candore, C Caruso, L Romeo, G Scapagnini: Alzheimer's disease: new diagnostic and therapeutic tools. Immun Ageing 5, 7 (2008)
44. D Uberti, C Lanni, T Carsana, S Francisconi, C Missale, M Racchi, S Govoni, M Memo: Identification of a mutant-like conformation of p53 in fibroblasts from sporadic Alzheimer's disease patients. Neurobiol Aging 27, 1193-1201 (2006) (Pubitemid 44067307)
45. D Uberti, C Lanni, M Racchi, S Govoni, M Memo: Conformationally altered p53: a putative peripheral marker for Alzheimer's disease. Neurodegener Dis 5, 209-211 (2008) (Pubitemid 351347852)
46. C Lanni, D Uberti, M Racchi, S Govoni, M Memo: Unfolded p53: a potential biomarker for Alzheimer's disease. J Alzheimers Dis 12, 93-99 (2007) (Pubitemid 47396308)
47. C Lanni, M Racchi, G Mazzini, A Ranzenigo, R Polotti, E Sinforiani, L Olivari, M Barcikowska, M Styczynska, J Kuznicki, A Szybinska, S Govoni, M Memo, D Uberti: Conformationally altered p53: a novel Alzheimer's disease marker? Mol Psychiatry 13, 641-647 (2008) (Pubitemid 351704936)
48. HY Wang, MR Pisano, E Friedman: Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol Aging 15, 293-298 (1994) (Pubitemid 24194869)
49. F Battaini, A Pascale, L Lucchi, GM Pasinetti, S Govoni: Protein kinase C anchoring deficit in postmortem brains of Alzheimer's disease patients. Exp Neurol 159, 559-564 (1999) (Pubitemid 29485243)
50. R Etcheberrigaray, M Tan, I Dewachter, C Kuiperi, I Van der Auwera, S Wera: Therapeutic effects of PKC activators in Alzheimer's disease transgenic mice. Proc Natl Acad Sci U S A 101, 11141-11146 (2004) (Pubitemid 38989597)
51. L Gasparini, M Racchi, G Binetti, M Trabucchi, SB Solerte, D Alkon, R Etcheberrigaray, G Gibson, J Blass, R Paoletti, S Govoni: Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease. FASEB J 12, 17-34 (1998) (Pubitemid 28060268)
52. DA Butterfield, R Sultana: Redox proteomics identification of oxidatively modified brain proteins in Alzheimer's disease and mild cognitive impairment: insights into the progression of this dementing disorder. J Alzheimers Dis 12, 61-72 (2007) (Pubitemid 47396301)
53. R Sultana, M Perluigi, DA Butterfield: Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: insights into mechanism of neurodegeneration from redox proteomics. Antioxid Redox Signal 8, 2021-2037 (2006) (Pubitemid 46499264)
54. MD Maines: The heme oxygenase system and its functions in the brain. Cell Mol Biol (Noisy-le-grand) 46, 573-585 (2000)
55. G Scapagnini, V D'Agata, V Calabrese, A Pascale, C Colombrita, D Alkon, S Cavallaro: Gene expression profiles of heme oxygenase isoforms in the rat brain. Brain Res 954, 51-59 (2002) (Pubitemid 35223440)
56. V Calabrese, R Sultana, G Scapagnini, E Guagliano, M Sapienza, R Bella, J Kanski, G Pennisi, C Mancuso, AM Stella, DA Butterfield: Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease. Antioxid Redox Signal 8, 1975-1986 (2006) (Pubitemid 46489625)
57. A Takeda, G Perry, NG Abraham, BE Dwyer, RK Kutty, JT Laitinen, RB Petersen, MA Smith: Overexpression of heme oxygenase in neuronal cells, the possible interaction with Tau. J Biol Chem 275, 5395-5399 (2000) (Pubitemid 30115170)
58. I Mateo, P Sánchez-Juan, E Rodríguez-Rodríguez, J Infante, JL Vázquez-Higuera, I García-Gorostiaga, J Berciano, O Combarros: Synergistic effect of heme oxygenase-1 and tau genetic variants on Alzheimer's disease risk. Dement Geriatr Cogn Disord 26, 339-342 (2008)
59. HM Schipper, H Chertkow, K Mehindate, D Frankel, C Melmed, H Bergman: Evaluation of heme oxygenase-1 as a systemic biological marker of sporadic AD. Neurology 54, 1297-1304 (2000) (Pubitemid 30174050)
60. HM Schipper, Y Mawal, H Chertkow, H Bergman: Blood HO-1 mRNA in AD and MCI. Neurology 57, 2142-2143 (2001) (Pubitemid 33126895)